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A 54-year-old patient presented with mild right-sided weakness of hand and face with a National Institutes of Health Stroke
Scale (NIHSS) of 2 and occlusion of the left middle cerebral artery (MCA) in the M1 segment with a large perfusion deficit on
computed tomography (CT). Due to mild neurological deficits no IVT was performed. Nine hours after symptom onset the patient
gradually deteriorated with a NIHSS fluctuating between 9 and 15. MRI showed a persistent occlusion of the MCA with a large
diffusion-perfusionmismatch. Immediate endovascular thrombectomywas performed 14 hours after symptomonsetwith complete
recanalization and complete clinical recovery. Although mechanical thrombectomy is generally considered an effective alternative
strategy up to 8 hours after stroke onset, selected patients with a large diffusion/perfusion mismatch and small infarct cores may
benefit from an expanded therapeutic window.
1. Background
For twodecades intravenous thrombolysis (IVT) has been the
most important therapy for patients with an acute ischemic
stroke [1]. However, eligibility of IVT is limited due to a
narrow time window of 4.5 hours after symptom onset with
a rapidly decreasing efficacy and various contraindications
such as comorbidities, oral anticoagulation, or recent surgery.
Furthermore, recanalization rates and outcome in patients
with large clots and proximal vessel occlusion are poor after
IVT [2].
Recently, data from several randomized clinical trials
demonstrated a clear benefit of endovascular treatment in
patients with acute ischemic stroke caused by a proximal
vessel occlusion in the anterior circulation [3]. Selection of
patients based on imaging—especially targeting for diffu-
sion/perfusion mismatch and excluding patients with a large
infarct core—has been shown to successfully avoid futile
interventions in all these trials [4].
Currently the time window for favorable outcome after
endovascular treatment is not well defined. Endovascular
treatment with stent retriever thrombectomy is recom-
mended up to 8 hours after symptom onset [5].
2. Case Presentation
A 54-year old, right-handed previously healthy male patient
presented with an acute right sided weakness and facial
palsy to a peripheral hospital (NIHSS on admission: 2).
Computed tomography (CT) angiography 4 hours and 20
minutes after symptom onset showed an occlusion of the
left MCA in the M1 segment with a large perfusion deficit
in the complete MCA territory. Since clinical symptoms
were very mild the treating physicians decided against IVT
and the patient received best medical treatment, that is,
250mg acetylsalicylic acid intravenously, Atorvastatin 40mg
per os, and enoxaparin 40mg s.c. He was transferred to
the local stroke unit for further monitoring. Within nine
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Figure 1: Cerebral magnetic resonance imaging 13 hours after stroke onset with a small diffusion lesion in the left basal ganglia and corona
radiata with a complete perfusion deficit of the leftMCA territory (a, b). Persistent occlusion of theMCA onmagnetic resonance angiography
((c), red arrow) and susceptibility weighted imaging ((d), red arrow). T2 weighted imaging 24 hours after the intervention showing a small
left sided basal ganglia infarction (e, f).
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hours after symptom onset the patient gradually deteriorated,
without any obvious cause (e.g., seizure, hypotension, and
fever). After transferal to our stroke center he presented with
severe aphasia and sensorimotor right-sided hemiparesis
with an NIHSS fluctuating between 9 and 15. Immediately
after admission to our hospital (i.e., 13 hours after stroke
onset), the patient underwent a cerebral magnetic resonance
imaging (MRI) (Figure 1) showing a small diffusion lesion
in the left basal ganglia and corona radiata with a complete
perfusion deficit of the left MCA territory and a persistent
occlusion of the MCA on magnetic resonance angiography
(MRA). The subsequent cerebral distraction angiography
(DSA) confirmed the complete occlusion of left MCA in the
M1 segment. After consent of the family the interventional
neuroradiologists performed mechanical thrombectomy in
conscious sedation. Complete recanalization was achieved
with the Solitaire retriever in one attempt 14 hours after stroke
onset. Angiography at the end of the intervention showed
a complete reperfusion of the former occluded left MCA
territory (TICI classification 3).
NIHSS immediately after the intervention was 4, and on
the following day 2 with a mild weakness of the right arm.
MRI 24 hours after intervention showed small left sided basal
ganglia infarction (Figure 1).The patient was retransferred to
the regional hospital 36 hours after intervention. One week
after symptom onset the patient reported to have completely
recovered.
3. Discussion
Endovascular treatment in acute stroke patients with occlu-
sion of large vessels in the anterior circulation improves func-
tional outcome [6]. Recanalization is associated with better
outcome and recanalization rateswithmechanical techniques
have been shown to be superior to pharmacological treatment
only [6]. Patients with mild or rapidly improving symptoms,
but proximal vessel occlusions have a poor outcome when
left untreated [6]. In an earlier study especially proximal
vessel occlusion and NIHSS ≥ 10 were predictors of poor
outcome patients with stroke with mild or rapidly improving
symptoms [7]. Therefore, rapid identification and treatment
of these patients are of major importance. In cases of
large vessel occlusion and low NIHSS with decision against
treatment in the acute phase, transferal to a stroke center
with endovascular treatment facilities for further monitoring
is highly recommended.
However, the time window for favorable outcome after
endovascular treatment is not well defined. Only very
recently first results of the DAWN study—presented on the
3rd European Stroke Organisation Conference in Prague and
not jet fully published—showed that removal of a clot by
endovascular thrombectomywithin up to 24 hours after onset
of signs and symptoms reduced the disability in selected
stroke patients, such as wake-up strokes [8]. As demon-
strated by Flint et al. and confirmed by Jovin et al. earlier,
endovascular treatment with stent retriever thrombectomy
within 8 hours after symptom onset is safe and reduces the
severity of poststroke disability [5, 9]. Whether mechanical
thrombectomy is beneficial in selected patients after 8 hours
remains unclear. Multimodal MRI imaging techniques have
been shown to better identify patients that are likely to benefit
from endovascular reperfusion therapy. Particularly patients
with a significant perfusion/diffusionmismatch onMRI have
substantial salvageable brain tissue that can be recovered
from ischemia after reperfusion by endovascular treatment,
showing better long-term clinical outcome [4]. Although
mechanical thrombus extraction is generally an alternative
strategy for acute revascularization up to 8 hours after stroke
onset [5, 9], selected patients may benefit from an expanded
therapeutic window. Therefore, further studies—and final
results from the DAWN trial—are needed to better define
time windows and multimodal imaging protocols for save
and efficient endovascular treatment in patients with acute
ischemic stroke.
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